0
0
Read Time:9 Second
Shilpa Medicare Limited has informed the Exchange about announces the approval of Nor Ursodeoxycholic Acid Tablets 500 mg for the treatment of Non-Alcoholic Fatty Liver Disease in India |SUBJECT: Product launch
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %